
COMMUNITY ONCOLOGY PRACTICE
Latest News

Latest Videos

Shorts










Podcasts
CME Content
More News

"AI can help clinicians translate unprecedented biological and clinical complexity into actionable insights," says Robert L. Ferris, MD, PhD.

Telehealth transplant consults help patients with multiple myeloma overcome racial, age, and rural barriers, speeding eligibility screening and expanding access to specialists.

Community oncology practices rapidly adopt bispecific therapy, but reimbursement gaps, intensive monitoring demands, and limited hospital coordination hinder safe, scalable in-office programs.

Real-world ESAS data show higher symptom burden after cancer diagnosis shifts spending from treatment to ER, home and mental health care.

A new NCCN survey found all responding cancer centers report at least one anti-cancer drug shortage, with 94% short on ifosfamide and 71% on carboplatin.

Learn how oncologists spot burnout early and cut it with smarter workflows, PTO coverage, supportive leadership, and AI-powered documentation.

Actionable strategies curb oncologist burnout by easing admin workload, enabling true PTO disconnect, strengthening leadership communication, and boosting self-care support.

Spot physician burnout early by recognizing emotional exhaustion, rising cynicism, and slipping effectiveness—before staff turnover and patient care suffer.

Almost one-third of patients became newly eligible for treatment after identification of a previously undetected druggable mutation.

Survey of 200+ oncology physicians reveals top burnout drivers—EMR burden, leadership gaps, poor work-life boundaries, and neglected self-care—pointing to systemic fixes.

Oncology leaders weigh how to scale trustworthy AI platforms, align governance, and integrate care-research workflows for real-world adoption.

AI-powered trial screening helps community oncology practices identify eligible patients locally, widening access beyond academic centers and reducing barriers such as distance and logistics.

Agentic AI speeds oncology trial screening by synthesizing records and ranking candidates, while clinicians keep final eligibility and consent decisions.



































